Breast cancers that lack ER, PR, and HER2 are known as Triple Negative Breast Cancer (TNBC), and they account for 15% to 20% of breast cancer tumours (Lee et al., 2019; Garrido-Castro et al., 2019). Here, ERBB2 is linked to breast carcinoma.